Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design

Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and designEffects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design, Published online: 05 December 2018; doi:10.1038/s41371-018-0139-xEffects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design

Source: Journal of Human Hypertension - December 5, 2018 Category: Cardiology Authors: Giacomo Rossitto Maurizio Cesari Giulio Ceolotto Giuseppe Maiolino Teresa Maria Seccia Gian Paolo Rossi Source Type: research